This review explores the cardiovascular consequences of opioids and the contributions of off-target electrophysiologic properties to mortality, and provides practical safety recommendations.
In patients with hypertension initiating treatment, effectiveness is comparable for ACE inhibitors and ARBs, but ARBs have a better safety profile.
A team of investigators evaluated the 2-year recurrent stroke risk in patients with symptomatic carotid web.
Intensive blood pressure reduction for acute ICH may increase the risk for death or disability in some patients with renal impairment.
Cardiovascular drugs do not affect COVID-19 outcomes, according to a review published online.
José-Alain Sahel, MD, Chairman of the Department of Ophthalmology at the University of Pittsburgh, and Hungarian researcher Botond Roska, MD, discuss a breakthrough that restored the sight of a patient with retinitis pigmentosa and light perception only.
Acute stroke treatment has been transformed by multimodal imaging tools, the report shows.
Omega-3 fatty acids (FAs) are associated with lower cardiovascular mortality and improved cardiovascular outcomes.
Study researchers sought to assess the link between Kawasaki disease and patient cognitive profiles or caregiver parenting stress.
This case report detailed a pediatric patient with progressive macrocephaly who presented with communicating hydrocephalus and intraventricular cerebrospinal fluid turbulence.
